Loading video.
VIDEO: UC San Diego students can participate in a nationwide clinical trial to assess how well a COVID-19 vaccine prevents infection and reduces risk of transmission. Watch this video to learn. view more
Credit: UC San Diego Health Sciences
COVID-19 vaccines were designed to reduce the likelihood that infection by the SARS-CoV-2 virus would lead to severe outcomes, such as hospitalization and death. In that sense, all of the currently approved vaccines Moderna, Pfizer and Johnson & Johnson have proven comparably effective.
But much less is known about the actual ability of these vaccines to prevent infection, most notably asymptomatic cases in which vaccinated persons might not become ill or display symptoms, but could still carry sufficient levels of the virus to pose a potential transmission threat to others.
Study on how successful are COVID-19 vaccines over time news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Our six dermatology products are marketed by our partner company, Journey Medical Corporation (“Journey”).
Our products generated net revenues of $44.5 million for full-year 2020, compared to full-year 2019 net revenues of $34.9 million, representing growth of 28%. Our products generated $13.7 million in revenues in the fourth quarter of 2020, compared to $11.1 million in the fourth quarter of 2019, representing growth of 23%. While we generated revenue growth year-over-year in 2020, sales of our products were impacted by the COVID-19 pandemic, which caused a temporary supply shortage and impacted the ability of our sales force to make in person calls, due to states slowly re-opening.
We in-licensed and recently launched our sixth prescription dermatology product.
WASHINGTON â A group of scientists that ran U.S. clinical trials for coronavirus vaccines last year is launching an ambitious new study to look at their effectiveness, including whether vaccinated people can become infected with COVID-19 and spread it to others.
The trials will also look at whether new variants of the coronavirus are able to infect and spread among vaccinated people more than the original virus.
The randomized, controlled study began enrolling more than 12,000 college students between 18 and 26 years old last week at more than 20 universities across the country. The students will self-swab their noses every day for four months to test for COVID-19 after receiving Modernaâs vaccine.